Candriam Equities L Biotechnology Class S JPY Unhedged Cap
Fund
ISIN LU1820816558 / Valor 41708408
NAV (2025-03-13)
JPY 319,817.00-1.23%
Candriam Equities L Biotechnology Class S JPY Unhedged Cap
UMushroom community rating:
0.00
0 votes
No rating yet
NegativeNeutralPositive
General Objective
The fund aims to achieve capital growth by investing in shares of companies operating in the biotechnology industry worldwide and outperforming the benchmark index. The management team makes discretionary investment choices based on economic/financial analyses, with a focus on clinical and fundamental analysis.
Fund Exposure
The fund is exposed to companies in the biotechnology industry, with a selection process based on clinical and fundamental analysis. The fund promotes environmental and/or social characteristics and excludes investments in companies that do not respect certain international standards. The analysis of ESG aspects is included in the selection and evaluation of companies.
Risks
Investors should be aware of risks related to financial derivative instruments, liquidity, sustainability, and concentration. The use of derivatives can accentuate downward movements, liquidity risk may affect the ability to liquidate securities quickly, sustainability risk could impact issuer performance, and concentration risk may lead to greater impact on assets in specific market segments.